Discover 722 paid clinical trials in Overland Park, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 722
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
for
Relapsed or Resistant Acute Leukaemias
Location: Fairway KS, Chapel Hill NC, Baltimore MD, Tampa FL
Sponsor: Lin BioScience, Inc
Sex: All
Age: 18 - 70+
Code: NCT05756322
Phase1, Phase2, Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for
Cardiovascular Disease and Lipoprotein(a)
Location: Kansas City KS, Topeka KS, City of Saint Peters MO,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07517263
Phase3, Recruiting
Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well
for
Acute Ischemic Stroke
Location: Kansas City KS, St Louis MO, Chicago IL, Dallas TX,
Sponsor: Amrou Sarraj
Sex: All
Age: 18 - 70+
Code: NCT07115940
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: Kansas City KS, Omaha NE, St Louis MO, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase2, Phase3, Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for
Relapsing Multiple Sclerosis
Location: Kansas City KS, St Louis MO, Chicago IL, Plano TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 40 - 70
Code: NCT06846281
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
for
Rheumatoid Arthritis, Interstitial Lung Disease
Location: Kansas City KS, Aurora CO, Ann Arbor MI,
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT06397677
Recruiting
Activity for Diabetic Polyneuropathy
for
Diabetic Neuropathy
Location: Kansas City KS, Salt Lake City UT
Sponsor: Virginia Commonwealth University
Sex: All
Age: 30 - 70+
Code: NCT02341261
Recruiting
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
for
Prostate Cancer, Lower Urinary Tract Symptoms
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT03802851
Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for
Degenerative Disc Disease, Disc Degeneration,
Location: Kansas City KS, Shreveport LA, Tyler TX, New Castle IN,
Sponsor: VIVEX Biologics, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06778447
Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Kansas City KS, Omaha NE, St Louis MO, Rochester MN,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06710756
Phase1, Phase2, Recruiting
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis
Location: Kansas City KS, Sioux Falls SD, Denison TX, Madison WI,
Sponsor: Cumberland Pharmaceuticals
Sex: All
Age: 40+
Code: NCT05571059
Phase2, Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Kansas City KS, Columbia MO, Springfield MO, Omaha NE,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT03907046
Phase3, Recruiting
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
for
Triple Negative Breast Cancer
Location: Westwood KS, St Louis MO, Germantown TN, Dallas TX,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06926920
Phase1, Phase2, Recruiting
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy